Science2002 Spinout Sessions - University of Pittsburgh


		All Spinout Sessions will be held in Alumni Hall (formerly Masonic Temple) Room 532.
		Science2002 spinout sessions are designed to provide a forum for scientists working in nonacademic settings to share their work. Check back frequently for updated information about this new addition to the festival.
		SESSION I: SCIENCE BEYOND THE LABORATORY
		James G. Dilmore, Ph.D. "From One Bench to Another: The Roles of a Basic Scientist at a Law Firm" Reed Smith
		Steven M. Hilton, J.D. "When Biology Meets Government" Buchanan Ingersoll
		Debra Z. Anderson, J.D. "Enabling Your Biotech Disclosure for a United States Patent Application" Eckert Seamans Cherin & Mellott
		Wednesday, September 18, 10:30 a.m.
		Room TBA

		SESSION II: OPERATIONALIZING DRUG DISCOVERY
		Philip E. Yeske, Ph.D. "Fluorous Technology in Drug Discovery Chemistry" Fluorous Technologies Herbert S. Bresler, Ph.D. "Commercial Delivery of Cell-Based Therapies--When Biology Meets Business" Battelle J. Mark Braughler, Ph.D. "Combined Histomorphometric and Gene Expression Profiling" TissueInformatics
		Wednesday, September 18, 2:00 p.m.
		Room TBA

		SESSION III: EXAMINING LIFE AT THE CELLULAR LEVEL
		Kris F. Sachsenmeier, Ph.D. *"Quantifying the Disease Phenotype In Vitro"*
		Automated Cell
		D. Lansing Taylor, Ph.D. "The Living Cell: A Window on LIfe" Cellomics
		Daniel R. Marshak, Ph.D. "Stem Cell Biology"
		Cambrex
		Thursday, September 19, 10:30 a.m.
		Room TBA

		SESSION IV: FROM NAPKIN SKETCH TO NEW TECHNOLOGY
		Matthew Beale "Partnering for Product Development Success" Daedalus Excel Elie Saad, Ph.D. "Baytron®, A New Generation of Conductive Polymer" Bayer Corporation
		.
		Reza Fathi, Ph.D. and Maryann Donovan, Ph.D. "Diversity-Oriented Synthesis: Creating Artificial Drugs with the Complexity of Natural Compounds" VivoQuest, Inc.
		Thursday, September 19, 2:00 p.m
		Room TBA